Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1981 Jul 1;154(1):204–209. doi: 10.1084/jem.154.1.204

Enhancement of delayed hypersensitivity reaction with varieties of anti- cancer drugs. A common biological phenomenon

PMCID: PMC2186397  PMID: 6788892

Abstract

Delayed hypersensitivity reaction in mice was commonly enhanced with various anti-cancer agents administered as single or intermittent high doses but not consecutive divided doses. The effect of anti-cancer agents on the delayed hypersensitivity reaction was thought to be due to elimination of suppressor T cell activity.

Full Text

The Full Text of this article is available as a PDF (317.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baba M., Harada T., Morikawa S. Studies on delayed hypersensitivity in mice. I, Physicochemical and biological properties of preferential antigens for inducing delayed hypersensitivity in mice. Acta Pathol Jpn. 1977 Mar;27(2):165–183. doi: 10.1111/j.1440-1827.1977.tb01867.x. [DOI] [PubMed] [Google Scholar]
  2. Blanke T. J., Little J. R., Shirley S. F., Lynch R. G. Augmentation of murine immune responses by amphotericin B. Cell Immunol. 1977 Sep;33(1):180–190. doi: 10.1016/0008-8749(77)90145-9. [DOI] [PubMed] [Google Scholar]
  3. Bruce W. R., Meeker B. E., Valeriote F. A. Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo. J Natl Cancer Inst. 1966 Aug;37(2):233–245. [PubMed] [Google Scholar]
  4. Crowle A. J., Patrucco A. Preferential development by mice of delayed hypersensitivity to purified basic proteins. J Allergy. 1968 Sep;42(3):140–156. doi: 10.1016/0021-8707(68)90087-7. [DOI] [PubMed] [Google Scholar]
  5. Diamantstein T., Willinger E., Reiman J. T-suppressor cells sensitive to cyclophosphamide and to its in vitro active derivative 4-hydroperoxycyclophosphamide control the mitogenic response of murine splenic B cells to dextran sulfate. A direct proof for different sensitivities of lymphocyte subsets to cyclophosphamide. J Exp Med. 1979 Dec 1;150(6):1571–1576. doi: 10.1084/jem.150.6.1571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Djerassi I., Rominger C. J., Kim J. S., Turchi J., Suvansri U., Hughes D. Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer. Cancer. 1972 Jul;30(1):22–30. doi: 10.1002/1097-0142(197207)30:1<22::aid-cncr2820300105>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  7. Frei E., 3rd Combination cancer therapy: Presidential address. Cancer Res. 1972 Dec;32(12):2593–2607. [PubMed] [Google Scholar]
  8. Gelehrter T. D. Enzyme induction (second of three parts). N Engl J Med. 1976 Mar 11;294(11):589–595. doi: 10.1056/NEJM197603112941105. [DOI] [PubMed] [Google Scholar]
  9. Glaser M. Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice. J Exp Med. 1979 Mar 1;149(3):774–779. doi: 10.1084/jem.149.3.774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hellström I., Hellström K. E. Cyclophosphamide delays 3-methylcholanthrene sarcoma induction in mice. Nature. 1978 Sep 14;275(5676):129–130. doi: 10.1038/275129a0. [DOI] [PubMed] [Google Scholar]
  11. Hillcoat B. L., McCulloch P. B., Figueredo A. T., Ehsan M. H., Rosenfeld J. M. Clinical response and plasma levels of 5-fluorouracil in patients with colonic cancer treated by drug infusion. Br J Cancer. 1978 Dec;38(6):719–724. doi: 10.1038/bjc.1978.278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lagrange P. H., Mackaness G. B., Miller T. E. Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J Exp Med. 1974 Jun 1;139(6):1529–1539. doi: 10.1084/jem.139.6.1529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mitsuoka A., Morikawa S., Baba M., Harada T. Cyclophosphamide eliminates suppressor T cells in age-associated central regulation of delayed hypersensitivity in mice. J Exp Med. 1979 May 1;149(5):1018–1028. doi: 10.1084/jem.149.5.1018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Morikawa S., Baba M., Harada T., Mitsuoka A. Studies on delayed hypersensitivity in mice. III. Evidence for suppressive regulatory T1-cell population in delayed hypersensitivity. J Exp Med. 1977 Feb 1;145(2):237–248. doi: 10.1084/jem.145.2.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rosen G., Tan C., Sanmaneechai A., Beattie E. J., Jr, Marcove R., Murphy M. L. The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma. Cancer. 1975 Mar;35(3 Suppl):936–945. doi: 10.1002/1097-0142(197503)35:3+<936::aid-cncr2820350714>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  16. Röllinghoff M., Starzinski-Powitz A., Pfizenmaier K., Wagner H. Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes. J Exp Med. 1977 Feb 1;145(2):455–459. doi: 10.1084/jem.145.2.455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Schwartz A., Orbach-Arbouys S., Gershon R. K. Participation of cyclophosphamide-sensitive T cells in graft-vs-host reactions. J Immunol. 1976 Sep;117(3):871–875. [PubMed] [Google Scholar]
  18. Sensenbrenner L. L., Owens A. H., Jr, Zawatzsky L. S., Elfenbein G. J. Comparative effects of selected cytotoxic agents on transplanted hematopoietic cells. Transplantation. 1972 Sep;14(3):347–351. doi: 10.1097/00007890-197209000-00010. [DOI] [PubMed] [Google Scholar]
  19. Tarnowski G. S., Faanes R. B., Ralph P., Williams N. Suppression and restoration of cytotoxic T-cell activity during chemotherapy of a mouse T-cell lymphoma and a macrophage tumor. Cancer Res. 1978 Dec;38(12):4540–4545. [PubMed] [Google Scholar]
  20. Turk J. L., Parker D., Poulter L. W. Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide. Immunology. 1972 Oct;23(4):493–501. [PMC free article] [PubMed] [Google Scholar]
  21. Van Dijk H., Voermans G. A. Cyclophosphamide-like cellular immunostimulation induced by 6-thioguanine (Lanvis). Immunology. 1978 Jun;34(6):1077–1081. [PMC free article] [PubMed] [Google Scholar]
  22. Yu S., Lannin D. R., Tsui-Collins A. L., McKhann C. F. Effect of cyclophosphamide on mice bearing methylcholanthrene-induced fibrosarcomas. Cancer Res. 1980 Aug;40(8 Pt 1):2756–2761. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES